These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 1908371)
1. [The kinetics of plasma coagulation fibrinolysis levels in acute myocardial infarction before and after treatment with intravenous urokinase]. Bai XJ; Chen CX; He YL Zhonghua Nei Ke Za Zhi; 1991 Apr; 30(4):205-7, 253. PubMed ID: 1908371 [TBL] [Abstract][Full Text] [Related]
2. [Serial changes in hemostatic and fibrinolytic states induced by coronary thrombolytic therapy]. Goto S; Handa S; Abe S; Takahashi E; Kawai Y; Watanabe K; Yoshikawa T; Hori S; Ikeda Y J Cardiol; 1993; 23(4):335-41. PubMed ID: 8064582 [TBL] [Abstract][Full Text] [Related]
3. [Effects of different treatments on plasma t-PA and PAI activity in AMI]. Zhu G Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Oct; 15(5):374-9. PubMed ID: 8168223 [TBL] [Abstract][Full Text] [Related]
4. [Effect of qigong on plasma coagulation fibrinolysis indices of hypertensive patients with blood stasis]. Wang CX; Xu DH Zhongguo Zhong Xi Yi Jie He Za Zhi; 1993 Jul; 13(7):415-6, 389. PubMed ID: 8251725 [TBL] [Abstract][Full Text] [Related]
5. Fibrinolysis and coagulation in patients with infectious disease and sepsis. Philippé J; Offner F; Declerck PJ; Leroux-Roels G; Vogelaers D; Baele G; Collen D Thromb Haemost; 1991 Mar; 65(3):291-5. PubMed ID: 1904655 [TBL] [Abstract][Full Text] [Related]
6. [Dynamic changes in fibrinolytic system in patients with acute myocardial infarction]. Zhang SY; Jin L; Zhu GJ Zhonghua Nei Ke Za Zhi; 1991 Dec; 30(12):743-5, 789. PubMed ID: 1815876 [TBL] [Abstract][Full Text] [Related]
7. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309 [TBL] [Abstract][Full Text] [Related]
8. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers. Siegbahn A; Ruusuvaara L Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043 [TBL] [Abstract][Full Text] [Related]
9. Effects of direct percutaneous transluminal coronary angioplasty treatment of acute myocardial infarction on plasma levels of haemostatic and fibrinolytic factors. Saito M; Nakabayashi T; Iuchi K; Ishikawa T; Kaseno K; Yoshida T; Asakura H; Matsuda T Blood Coagul Fibrinolysis; 1993 Oct; 4(5):801-4. PubMed ID: 7507363 [TBL] [Abstract][Full Text] [Related]
10. Magnesium therapy, fibrinolytic parameters and von Willebrand factor in acute myocardial infarction. Thögersen AM; Jansson JH; Wester PO Int J Cardiol; 1996 Sep; 56(1):53-9. PubMed ID: 8891805 [TBL] [Abstract][Full Text] [Related]
11. Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction. Goto S; Kawai Y; Abe S; Takahashi E; Handa S; Ogawa S; Watanabe K; Hori S; Ikeda Y Angiology; 1994 Apr; 45(4):273-81. PubMed ID: 8161005 [TBL] [Abstract][Full Text] [Related]
12. Changes in plasma levels of tissue plasminogen activator and its inhibitor in aged myocardial infarction patients. Chen HZ; Jia HY; Song HY; Wang JY Chin Med J (Engl); 1990 Jul; 103(7):541-5. PubMed ID: 2119970 [TBL] [Abstract][Full Text] [Related]
13. Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endothelium. Munkvad S; Jespersen J; Gram J; Kluft C J Intern Med; 1990 Oct; 228(4):361-6. PubMed ID: 1702458 [TBL] [Abstract][Full Text] [Related]
14. Procoagulant effects of thrombolytic therapy in acute myocardial infarction. Wang Y; Liu Q; Zhu J; Yuan Z; Ma X Chin Med Sci J; 2002 Mar; 17(1):36-9. PubMed ID: 12894883 [TBL] [Abstract][Full Text] [Related]
15. Association of patency of the infarct-related coronary artery with plasma levels of plasminogen activator inhibitor activity in acute myocardial infarction. Sakamoto T; Yasue H; Ogawa H; Misumi I; Masuda T Am J Cardiol; 1992 Aug; 70(3):271-6. PubMed ID: 1632387 [TBL] [Abstract][Full Text] [Related]
16. [Changes in coagulation and fibrinolysis in the patients with coronary heart disease in acute period and effect of drug intervention]. Jia XQ; Dong CM; Qin J; Zhang L Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Apr; 24(4):225-8. PubMed ID: 22464576 [TBL] [Abstract][Full Text] [Related]
17. [An experimental study of local fibrinolysis using tissue plasminogen activator and urokinase in a canine common carotid artery thrombus model]. Kawakami K; Takahashi A; Yoshimoto T No To Shinkei; 1990 Feb; 42(2):193-201. PubMed ID: 2113401 [TBL] [Abstract][Full Text] [Related]
18. [New thrombolytic agents in myocardial infarction]. Charbonnier B; Lang M; Brochier M Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222 [TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways. Munkvad S Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763 [TBL] [Abstract][Full Text] [Related]
20. von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator. Schved JF; Gris JC; Arnaud A; Martinez P; Sanchez N; Wautier JL; Sarlat C J Lab Clin Med; 1992 Sep; 120(3):411-9. PubMed ID: 1517688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]